在中间前额叶皮质中的金字塔神经元中的多巴胺D2受体调节社会行为
Hao Chen1, Xing-Xing Xiong1, Shi-Yang Jin1
1Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Pharmacological research
|December 24, 2023
概括
位于中间前额叶皮层 (mPFC) 的多巴胺D2受体 (Drd2) 调节社会行为. 激活Drd2会损害社交互动,而阻止它会通过mPFC到核accumbens通道加强社交互动.
科学领域:
- 神经科学是一个神经科学.
- 行为科学 行为科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多巴胺D2受体 (Drd2) 是神经精神疾病,如精神分裂症的关键目标.
- 社会缺陷是这些疾病的核心症状,但神经回路尚未完全理解.
- 中间前额叶皮层 (mPFC) 在社会行为中发挥作用,但表达Drd2的特定神经元群落仍然不清楚.
研究的目的:
- 研究mPFC中Drd2表达神经元在调节社会行为的作用.
- 阐明Drd2对社会互动的影响的具体神经元亚型和电路机制.
主要方法:
- 在雄性小鼠中利用了有条件的淘汰和光遗传学操纵.
- 检查了mPFC金字塔神经元中的Drd2表达.
- 在社交互动过程中,研究了mPFC-to-nucleus accumbens (NAc) 途径中的神经元活动.
主要成果:
- Drd2主要表达在mPFC金字塔神经元中.
- 在Drd2+金字塔神经元中Gi通路的激活会影响社会行为.
- 在mPFC金字塔神经元中的D2受体的淘汰增强了社交方法行为.
- 在社交互动期间,D2R淘汰促进了mPFC-to-NAc通路的激活.
结论:
- 在mPFC金字塔神经元中的Drd2在社会行为调节中起着关键的,细胞类型特定的作用.
- 从mPFC到NAc的通路是调解这些效应的关键电路.
- 这些发现表明神经精神疾病中社会缺陷的潜在治疗点.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Neurotransmitters
958
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
958
Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Regulation of Food Intake
239
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
239
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
332
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
332


